Seres Therapeutics, Inc. (MCRB)

Seres Therapeutics Revenue

Seres Therapeutics had revenue of $126.33M in the twelve months ending September 30, 2024, up 12,856.41% year-over-year. In the year 2023, Seres Therapeutics had annual revenue of $126.33M with 1,672.24% growth.

• Revenue (ttm): $126.33M
• Revenue Growth: +12,856.41%
• P/S Ratio: 0.88
• Revenue / Employee: $542,167
• Employees: 233
• Market Cap: 131.02M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	126.33M	119.20M	1,672.24%
Dec 31, 2022	7.13M	-137.80M	-95.08%
Dec 31, 2021	144.93M	111.71M	336.33%
Dec 31, 2020	33.22M	-1.29M	-3.74%
Dec 31, 2019	34.51M	6.24M	22.07%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.